Ginkgo Going Public with ~1.63B in Proceed Via Soaring Eagle SPAC Merger

September 15, 2021 Auto Bot M&A 0

Shots:

  • The merger was approved in a shareholder vote with 75% participation & 97% in favor of the combination. Upon the closing of the merger, Ginkgo is eligible to receive ~1.63B in gross proceeds including $775M from a PIPE and ~$858M from the Soaring Eagle trust account
  • Soaring Eagle will now change its name to Ginkgo Bioworks and the combined company’s shares of Class A common stock will trade on NYSE under the ticker symbols “DNA and DNA.WS” respectively
  • Ginkgo has built a platform for cell programming that can be used by companies across multiples industries to develop products such as food ingredients, fragrances, cosmetics & medicines respectively

Click here to read full press release/ article | Ref: Businesswire | Image: PR Newswire

The post Ginkgo Going Public with ~1.63B in Proceed Via Soaring Eagle SPAC Merger first appeared on PharmaShots.